Cronos Group Executive and Leadership Team

Michael Gorenstein, the Chairman, President & Chief Executive Officer at Cronos Group, directs the overarching corporate strategy and long-term vision for the organization. Gorenstein manages high-level relationships with global stakeholders and investors to ensure alignment with the company's mission of cannabinoid innovation. By overseeing the integration of international production assets, the Chairman, President & Chief Executive Officer drives market expansion across five continents. This leadership role involves constant evaluation of regulatory landscapes and emerging industry trends to maintain a competitive edge. Michael Gorenstein actively shapes the organizational culture and prioritizes sustainable growth initiatives. Through the coordination of executive leadership teams, the Chairman, President & Chief Executive Officer secures the financial health and operational integrity of the enterprise. Strategic decision-making remains the primary focus, ensuring that the company consistently delivers value within the complex global manufacturing sector.

Anna Shlimak, the Chief Financial Officer at Cronos Group, directs all fiscal planning, capital allocation, and financial reporting activities. Shlimak manages the company's balance sheet and ensures compliance with international accounting standards across all operating regions. By overseeing the budgeting process and financial forecasting, the Chief Financial Officer provides the necessary data to support strategic investment decisions. This leadership role involves frequent interaction with the Board to communicate financial performance and risk management strategies. Anna Shlimak drives the development of financial models that evaluate the viability of new market entries and product lines. Through the rigorous oversight of cash flow and expenditure, the Chief Financial Officer maintains the fiscal stability required for long-term growth. Shlimak ensures that all financial operations remain transparent and aligned with the company's commitment to excellence in the global cannabinoid market.

Mike Kroslak, the Chief Operating Officer at Cronos Group, oversees the internal scaling of production facilities and the optimization of manufacturing workflows. Kroslak directs the implementation of standardized operational procedures across international sites to ensure consistent product quality. By managing the day-to-day execution of business processes, the Chief Operating Officer maintains high efficiency levels within the global supply chain. This role requires constant collaboration with regional managers to address logistical challenges and improve output capacity. Mike Kroslak monitors performance metrics to identify areas for process improvement and cost reduction. Through the application of lean manufacturing principles, the Chief Operating Officer supports the company's ability to meet rising demand in diverse markets. Operational excellence remains the core objective, with Kroslak ensuring that all production activities align with the broader strategic goals established by the executive leadership team.

Dinor Levi, the Co-founder & Chief Operating Officer at Cronos Group, directs the strategic development of supply chain logistics and distribution networks. Levi manages the complex movement of products across international borders, ensuring that global operations meet strict regulatory requirements. By overseeing the integration of new distribution partners, the Co-founder & Chief Operating Officer expands the company's reach into emerging markets. This role involves coordinating with external vendors and internal teams to optimize inventory management and reduce lead times. Dinor Levi monitors global market dynamics to adjust supply chain strategies in real-time. Through the implementation of advanced tracking and logistics technology, the Co-founder & Chief Operating Officer enhances the reliability of the company's distribution infrastructure. Levi focuses on building resilient systems that support the company's mission to provide high-quality cannabinoid products to a diverse, international customer base.